We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+0.73%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$24.1B
AUM Growth
+$1.97B
Cap. Flow
+$2.04B
Cap. Flow %
8.47%
Top 10 Hldgs %
10.49%
Holding
3,709
New
1,117
Increased
953
Reduced
622
Closed
747

Sector Composition

Rank Sector Weight
1 Healthcare 20.28%
2 Financials 16.56%
3 Technology 13.74%
4 Consumer Discretionary 11.01%
5 Communication Services 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMP icon
2776
Tompkins Financial
TMP
$1.43B
$208K ﹤0.01%
+2,569
New +$199K
AMPS
2777
DELISTED
Altus Power
AMPS
$208K ﹤0.01%
+20,918
New +$207K
SMIH
2778
DELISTED
Summit Healthcare Acquisition Corp. Class A Ordinary Share
SMIH
$208K ﹤0.01%
+21,304
New +$205K
LTRX icon
2779
Lantronix
LTRX
$264M
$207K ﹤0.01%
35,648
-44,608
-56% -$245K
KHC icon
2780
Kraft Heinz
KHC
$29.2B
$206K ﹤0.01%
+5,596
New +$211K
WIMI
2781
WiMi Hologram Cloud
WIMI
$24.5M
$206K ﹤0.01%
5,006
-19,479
-80% -$821K
IMOS
2782
ChipMOS TECHNOLOGIES
IMOS
$2.06B
$204K ﹤0.01%
+5,963
New +$231K
AGCWW
2783
CALL
DELISTED
Altimeter Growth Corp Warrant
AGCWW
$204K ﹤0.01%
19,993
ASUR icon
2784
Asure Software
ASUR
$243M
$203K ﹤0.01%
22,534
-8,829
-28% -$77.6K
VIP
2785
Vulcan Infrastructure and Power Inc. Class A Common Stock
VIP
$30.5M
$203K ﹤0.01%
+796
New +$244K
IMNM icon
2786
Immunome
IMNM
$2.97B
$203K ﹤0.01%
+8,348
New +$146K
MDLZ icon
2787
Mondelez International
MDLZ
$78.9B
$203K ﹤0.01%
3,481
-100,851
-97% -$6.27M
BMY icon
2788
CALL
Bristol-Myers Squibb
BMY
$130B
$202K ﹤0.01%
+3,400
New +$224K
RGP icon
2789
Resources Connection
RGP
$144M
$202K ﹤0.01%
+12,797
New +$193K
VTRS icon
2790
PUT
Viatris
VTRS
$18.7B
$202K ﹤0.01%
+14,900
New +$211K
B
2791
Barrick Mining
B
$66B
$201K ﹤0.01%
11,174
-47,625
-81% -$956K
ANIX icon
2792
Anixa Biosciences
ANIX
$110M
$200K ﹤0.01%
+41,973
New +$189K
ATNM icon
2793
Actinium Pharmaceuticals
ATNM
$24.9M
$199K ﹤0.01%
+22,469
New +$156K
BCBP icon
2794
BCB Bancorp
BCBP
$158M
$199K ﹤0.01%
13,453
-35,593
-73% -$519K
AAIC
2795
DELISTED
Arlington Asset Investment Corp.
AAIC
$199K ﹤0.01%
+53,876
New +$205K
THCPW
2796
CALL
DELISTED
Thunder Bridge Capital Partners IV, Inc. Warrant
THCPW
$197K ﹤0.01%
+20,296
New +$19.4K
YRD
2797
Yiren Digital
YRD
$108M
$193K ﹤0.01%
63,979
+38,673
+153% +$153K
IQ icon
2798
iQIYI
IQ
$1.3B
$191K ﹤0.01%
23,725
-2,815,023
-99% -$29.2M
TEVA icon
2799
Teva Pharmaceuticals
TEVA
$42.5B
$190K ﹤0.01%
+19,446
New +$182K
C icon
2800
PUT
Citigroup
C
$228B
$189K ﹤0.01%
2,700
+2,200
+440% +$154K

Similar funds

Marshall Wace's Q3 2021 Portfolio in Review

As of Q3 2021, Marshall Wace held 3,709 positions worth $24.1B, up 8.9% from $22.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $2.04B of net new capital in Q3 2021, opening 1,117 new positions and adding to 953 existing holdings. Its largest new stake was SkinHealth Systems: 4,113,430 shares worth $107M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Biogen, an estimated $210M trimmed.

  • Marshall Wace's largest Q3 2021 buy was SkinHealth Systems: 4,113,430 shares worth $107M.
  • Marshall Wace added most to Uber in Q3 2021, an estimated $127M increase.
  • Marshall Wace's biggest Q3 2021 reduction was Biogen, cutting an estimated $210M.
  • Marshall Wace fully exited Vipshop in Q3 2021, selling an estimated $58.7M.
  • Marshall Wace's ten largest holdings make up 10% of its $24.1B portfolio in Q3 2021.
  • Marshall Wace opened 1,117 new positions and closed 747 in Q3 2021.
  • Marshall Wace's portfolio value rose 8.9% quarter-over-quarter to $24.1B.

Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.